{"database": "lobbying", "table": "lobbying_activities", "rows": [[489534, "b4e7dfec-c7c7-4088-9b36-e995b04e00cc", "YY", "SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.", 34502, "SCHERING-PLOUGH LEGISLATIVE RESOURCES L L C", 2006, "year_end", "TRD", "Legislation regarding duty suspension for Ezetimibe:  H.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.\r\nH.R.2077, To suspend temporarily the duty on Garenoxacin mesylate; H.R.2079, To extend the temporary duty suspension on Ezetimibe; S.1551, Protecting Free Trade in Pharmaceuticals Act of 2005.", "HOUSE OF REPRESENTATIVES,SENATE", null, 820000, 0, 0, "2007-02-14T14:11:41-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["489534"], "units": {}, "query_ms": 0.7584730046801269, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}